BioGaia AB (publ) (BIOG_B) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biogaia Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.057 Welcome to Biogea Q3 report for 2025. For the first part of the 00:00:05.057 -- 00:00:08.762 conference call, the participants will be in listen-only mode. 00:00:08.762 -- 00:00:13.808 During the questions and answers session, participants are able to ask questions by dialing 00:00:13.808 -- 00:00:19.095 pound key 5 on their telephone keypad. Now I will hand the conference over to CEO 00:00:19.095 -- 00:00:24.500 Teresa Agnew and CFO Alexander Katsinas. Please go ahead. 00:00:24.500 -- 00:00:29.868 Hi, this is Teresa Agnew, CEO of BioGaia, and Alex and I are here to present 00:00:29.868 -- 00:00:32.789 our Q3 results. 00:00:33.393 -- 00:00:35.796 So sales were 327 00:00:35.796 -- 00:00:40.380 million SEC, which is an increase of 7% 00:00:40.843 -- 00:00:44.929 due to higher sales in America as well as Asia Pacific. 00:00:44.929 -- 00:00:47.593 Growth overall was 14% 00:00:47.593 -- 00:00:54.021 when excluding currency effects. Year to date, our growth is 8% excluding 00:00:54.021 -- 00:00:58.210 currency effects and 4% including currency. 00:00:58.210 -- 00:01:03.461 Our sales in Asia Pacific for the quarter increased by 17%, in Americas 00:01:03.461 -- 00:01:09.193 increased by 10%, and in EMEA decreased by 4%, primarily 00:01:09.193 -- 00:01:14.453 due to sales in Eastern Europe. We saw strong growth following increased 00:01:14.453 -- 00:01:18.120 media investments in the US and other prioritized 00:01:18.120 -- 00:01:22.067 direct markets such as Canada, the UK and Australia. 00:01:22.067 -- 00:01:27.817 With our increased media, we've been attracting new consumers, new consumers to the brand 00:01:27.817 -- 00:01:32.897 and enhancing our brand awareness. For the quarter, our EBIT is 86 million 00:01:32.897 -- 00:01:36.560 sec,...